Word

ZABBIO

Status

Dead

Status Code

606

Status Date

Monday, June 29, 2020

Serial Number

87628754

Mark Type

4000

Filing Date

Friday, September 29, 2017

Published for Opposition

Tuesday, April 2, 2019

Abandoned Date

Monday, June 29, 2020

Trademark Owner History

ZabBio, Inc. - Owner At Publication

Classifications

1 Diagnostic reagents for scientific or research use; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Reagents for chemical analysis, other than for medical or veterinary purposes; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Reagents for use in scientific apparatus for chemical or biological analysis; Reagents for use in infectious disease research

10 Contraceptive apparatus; Intra uterine contraceptive devices; Contraceptive vaginal rings; Medical apparatus for introducing pharmaceutical preparations into the human body

42 Pharmaceutical research and development; research and development of pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, viral and infectious diseases, cancer, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, sexually transmitted infections including, but not limited to, HIV, HPV, and herpes and hemolytic diseases and disorders; research and development of pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, urological preparations, contraceptives, ophthalmologic preparations, tissue and skin repair preparations and gynecological preparations; research and development of drug delivery devices; medical and scientific research, namely, conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Pharmaceutical research and development in relation to infectious disease prevention and therapy

Trademark Events

Jun 29, 2020

Abandonment Notice Mailed - No Use Statement Filed

Jun 29, 2020

Abandonment - No Use Statement Filed

Nov 14, 2019

Notice Of Approval Of Extension Request Mailed

Nov 12, 2019

Extension 1 Granted

Nov 12, 2019

Extension 1 Filed

Nov 12, 2019

Teas Extension Received

May 28, 2019

Noa Mailed - Sou Required From Applicant

Apr 2, 2019

Published For Opposition

Mar 13, 2019

Notice Of Publication

Feb 27, 2019

Approved For Pub - Principal Register

Feb 26, 2019

Teas/Email Correspondence Entered

Feb 26, 2019

Correspondence Received In Law Office

Feb 26, 2019

Teas Response To Office Action Received

Jan 31, 2019

Non-Final Action Mailed

Jan 31, 2019

Non-Final Action Written

Jan 11, 2019

Lie Checked Susp - To Atty For Action

Jan 10, 2019

Assigned To Lie

May 17, 2018

Letter Of Suspension Mailed

May 17, 2018

Suspension Letter Written

May 15, 2018

Teas/Email Correspondence Entered

May 14, 2018

Correspondence Received In Law Office

May 14, 2018

Teas Response To Office Action Received

Jan 8, 2018

Non-Final Action Mailed

Jan 8, 2018

Non-Final Action Written

Jan 8, 2018

Assigned To Examiner

Oct 5, 2017

New Application Office Supplied Data Entered In Tram

Oct 3, 2017

New Application Entered In Tram